Trial Site Detail

 

Drug:	Nilotinib or Imatinib
Trial:	Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients (ENESTg1)
Conditions:	Gastrointestinal Stromal Tumor
Trial Status:	Completed

 

Parkland Health & Hospital System       Dallas , TX 75390 USA

 

Principal Investigator:	Yull Arriaga, MD
Contact:	Yull Arriaga, MD 214-648-4180 Yull.Arriaga@utsouthwestern.edu
Activation Status of this Site:	Closed
Notes about this Site:
Parkland Health & Hospital System Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.